Remove Allergies Remove Cardiology Remove Genetics Remove Medicine
article thumbnail

Improving European healthcare through cell-based interceptive medicine

Scienmag

Credit: Felix Petermann, MDC Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare.

article thumbnail

Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update

The Pharma Data

Progressed European regulatory review and commercial preparations : Continued to support regulatory review of VASCEPA by the European Medicines Agency (EMA) with the expectation of an early 2021 approval of VASCEPA for commercial sale in Europe. Patients with such allergies should discontinue VASCEPA if any reactions occur.

Sales 40